← Back to all trials
Not Yet Recruiting
NCT07742150
Placebo Effect in Field-Based Physical Performance
Conditions: Physical Performance, Placebo Effect, Cognitive Performance
Sex: All
Ages: 20 Years – 35 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 120
Sponsor: Poznan University of Physical Education
Location: Poznan University of Physical Education Poznan Greater Poland Voivodeship
Summary
This study aims to investigate the placebo (PLA) effect on physical performance across different sports disciplines in real-world, field-based settings. The study investigates how participant expectations and beliefs regarding caffeine (CAF) intake influence physical performance and psychomotor function outside the controlled laboratory environment. Healthy, physically active adults (n = 120) from diverse sports backgrounds will be randomly assigned to receive caffeine, placebo, or no intervention. Participants will perform discipline-specific field exercise tests (e.g., running-based protocols or repeated sprint protocols) while physiological responses are monitored using wearable technology. Physical performance outcomes and psychomotor responses will be analyzed to evaluate the real-world impact of the placebo effect and to distinguish the pharmacological effects of caffeine from those driven by psychological expectations across different athletic settings.
Eligibility Criteria
Inclusion Criteria:
* Age between 20 and 35 years,
* Healthy adults,
* Regular physical activity,
* Normal or corrected-to-normal vision,
* Habitual caffeine consumption.
Exclusion Criteria:
* History of neurological, psychiatric, cardiovascular, or metabolic disorders,
* Current use of medication or supplements affecting the central nervous system,
* Musculoskeletal injuries that would impair physical performance,
* No habitual caffeine consumption or severe negative side effects of caffeine,
* Diagnosed sleep disorders or chronic fatigue,
* Diagnosed major depressive disorder or other severe psychiatric conditions,
* Presence of any menstrual disorders,
* Inability to attend all experimental study visits.
Source: ClinicalTrials.gov (NCT07742150). StuddyBuddy aggregates publicly available trial information.